Reprogramming the Tumor Microenvironment: Calebin A as a Polyphenolic Paradigm Shift in Controlling Inflammation, Stemness, and Resistance in Colorectal Cancer
Drug Development Research · 2026
DOI: 10.1002/ddr.70230 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Development Research, 2026. Verfasst von Abdullah A Alshehri und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, College of Pharmacy, Taif University, Taif, Saudi Arabia. Hauptthemen laut MEDLINE: Tumor Microenvironment, Colorectal Neoplasms, Polyphenols. Die Arbeit nennt 58 Literaturangaben.
Abstract (Originalsprache)
Colorectal cancer (CRC) remains a leading cause of cancer mortality worldwide, largely due to inflammation‐driven progression, cancer stemness, and multidrug resistance (MDR). The tumor microenvironment (TME) orchestrates these hallmarks through persistent NF‐κB activation and cross‐talk among stromal, immune, and cancer cells. This review consolidates mechanistic evidence on Calebin A (CA), a non‐curcuminoid polyphenol from Curcuma longa, as a novel multitargeted agent capable of reprogramming the TME and redefining anticancer therapy. A literature integration was conducted across in vitro, ex vivo, and 3D TME models to assess CA's molecular targets, signaling pathways, and pharmacological challenges. CA directly interacts with redox‐sensitive cysteine residues in NF‐κB (p65) and IKKβ, inhibiting their activation and downstream transcriptional programs. This leads to decreased expression of MMP‐9, CXCR4, β1‐integrin, and CSC markers (CD44, CD133, ALDH1), along with activation of caspase‐3–mediated apoptosis. Moreover, CA reverses MDR by suppressing cytokine‐mediated stromal signaling, normalizing redox balance, and enhancing chemosensitivity to 5‐FU and cisplatin. Emerging data from other malignancies reveal CA's ability to modulate STAT3, Wnt/β‐catenin, and PI3K/Akt pathways, highlighting its universal microenvironmental reprogramming potential. Calebin A represents a polyphenolic paradigm shift in oncology—an agent that restores systemic homeostasis within the TME rather than merely inhibiting oncogenic pathways. Overcoming bioavailability challenges through nanotechnology and combination therapy may accelerate its clinical translation, positioning CA as a prototype for next‐generation ecological therapeutics in cancer management. This review consolidates mechanistic evidence on Calebin A (CA), a non‐curcuminoid polyphenol from Curcuma longa, as a novel multitargeted agent capable of reprogramming the TME and redefining anticancer therapy. A literature integration was conducted across in vitro, ex vivo, and 3D TME models to assess CA's molecular targets, signaling pathways, and pharmacological challenges. CA directly interacts with redox‐sensitive cysteine residues in NF‐κB (p65) and IKKβ, inhibiting their activation and downstream transcriptional programs. This leads to decreased expression of MMP‐9, CXCR4, β1‐integrin, and CSC markers (CD44, CD133, ALDH1), along with activation of caspase‐3–mediated apoptosis. Moreover, CA reverses MDR by suppressing cytokine‐mediated stromal signaling, normalizing redox balance, and enhancing chemosensitivity to 5‐FU and cisplatin. Emerging data from other malignancies reveal CA's ability to modulate STAT3, Wnt/β‐catenin, and PI3K/Akt pathways, highlighting its universal microenvironmental reprogramming potential. Calebin A represents a polyphenolic paradigm shift in oncology—an agent that restores systemic homeostasis within the TME rather than merely inhibiting oncogenic pathways. Overcoming bioavailability challenges through nanotechnology and combination therapy may accelerate its clinical translation, positioning CA as a prototype for next‐generation ecological therapeutics in cancer management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, College of Pharmacy, Taif University, Taif, Saudi Arabia.
ORCID-Profile: Abdullah A Alshehri
Zitieren
APA
Alshehri, A. A., & Khawagi, W. Y. (2026). Reprogramming the Tumor Microenvironment: Calebin A as a Polyphenolic Paradigm Shift in Controlling Inflammation, Stemness, and Resistance in Colorectal Cancer. Drug Development Research. https://doi.org/10.1002/ddr.70230
Vancouver
Alshehri AA, Khawagi WY. Reprogramming the Tumor Microenvironment: Calebin A as a Polyphenolic Paradigm Shift in Controlling Inflammation, Stemness, and Resistance in Colorectal Cancer. Drug Development Research. 2026. doi:10.1002/ddr.70230
BibTeX
@article{Alshehri2026,
author = {Alshehri, Abdullah A and Khawagi, Wael Y},
title = {Reprogramming the Tumor Microenvironment: Calebin A as a Polyphenolic Paradigm Shift in Controlling Inflammation, Stemness, and Resistance in Colorectal Cancer},
journal = {Drug Development Research},
year = {2026},
doi = {10.1002/ddr.70230}
}
EUVIMED